wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35701298-379214E7-2710-46F5-918F-99BD29C83180
Q35701298-379214E7-2710-46F5-918F-99BD29C83180
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35701298-379214E7-2710-46F5-918F-99BD29C83180
Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation.
P2860
Q35701298-379214E7-2710-46F5-918F-99BD29C83180
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35701298-379214E7-2710-46F5-918F-99BD29C83180
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e579c105e93b2c70339ef77934502d52f60fa1c
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.